Orphazyme sells entire business to US biotech company
Embattled biotech company Orphazyme has found a buyer in the form of a US-based biotech firm. If and when the deal is completed, the Danish company will close, and the majority of the remaining 20 employees will be transferred to the new owner.
by christian bundgaard, translated by catherine brett
Orphazyme has found a buyer after months of speculation.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
.jpg)
Orphazyme creditors approve restructuring plan
For subscribers
